+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA Clinical Nutrition Market By Route of Administration, By Application, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5094330
  • Report
  • May 2020
  • Region: Africa, Middle East
  • 104 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • B. Braun Melsungen AG
  • BASF SE
  • Hero Nutritionals, Inc.
  • Lonza Group AG
The Latin America, Middle East and Africa Clinical Nutrition Market is expected to witness market growth of 7.9% CAGR during the forecast period (2020-2026).

Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.

Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, is expected to benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.

The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country is expected to fuel market growth.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study

Market Segmentation:

By Route of Administration
  • Oral
  • Enteral and
  • Parenteral

By Application
  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • B. Braun Melsungen AG
  • BASF SE
  • Hero Nutritionals, Inc.
  • Lonza Group AG

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Clinical Nutrition Market, by Route of Administration
1.4.2 LAMEA Clinical Nutrition Market, by Application
1.4.3 LAMEA Clinical Nutrition Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players
Chapter 4. LAMEA Clinical Nutrition Market by Route Of Administration
4.1 LAMEA Oral Market by Country
4.2 LAMEA Enteral Market by Country
4.3 LAMEA Parenteral Market by Country
Chapter 5. LAMEA Clinical Nutrition Market by Application
5.1 LAMEA Cancer Market by Country
5.2 LAMEA Neurological Diseases Market by Country
5.2.1.1 LAMEA Gastrointestinal Disorders Market by Country
5.3 LAMEA Metabolic Disorders Market by Country
5.4 LAMEA Other Applications Market by Country
Chapter 6. LAMEA Clinical Nutrition Market by End User
6.1 LAMEA Adults Clinical Nutrition Market by Country
6.2 LAMEA Pediatric Market by Country
6.3 LAMEA Geriatric Market by Country
Chapter 7. LAMEA Clinical Nutrition Market by Country
7.1 Brazil Clinical Nutrition Market
7.1.1 Brazil Clinical Nutrition Market by Route Of Administration
7.1.2 Brazil Clinical Nutrition Market by Application
7.1.3 Brazil Clinical Nutrition Market by End User
7.2 Argentina Clinical Nutrition Market
7.2.1 Argentina Clinical Nutrition Market by Route Of Administration
7.2.2 Argentina Clinical Nutrition Market by Application
7.2.3 Argentina Clinical Nutrition Market by End User
7.3 UAE Clinical Nutrition Market
7.3.1 UAE Clinical Nutrition Market by Route Of Administration
7.3.2 UAE Clinical Nutrition Market by Application
7.3.3 UAE Clinical Nutrition Market by End User
7.4 Saudi Arabia Clinical Nutrition Market
7.4.1 Saudi Arabia Clinical Nutrition Market by Route Of Administration
7.4.2 Saudi Arabia Clinical Nutrition Market by Application
7.4.3 Saudi Arabia Clinical Nutrition Market by End User
7.5 South Africa Clinical Nutrition Market
7.5.1 South Africa Clinical Nutrition Market by Route Of Administration
7.5.2 South Africa Clinical Nutrition Market by Application
7.5.3 South Africa Clinical Nutrition Market by End User
7.6 Nigeria Clinical Nutrition Market
7.6.1 Nigeria Clinical Nutrition Market by Route Of Administration
7.6.2 Nigeria Clinical Nutrition Market by Application
7.6.3 Nigeria Clinical Nutrition Market by End User
7.7 Rest of LAMEA Clinical Nutrition Market
7.7.1 Rest of LAMEA Clinical Nutrition Market by Route Of Administration
7.7.2 Rest of LAMEA Clinical Nutrition Market by Application
7.7.3 Rest of LAMEA Clinical Nutrition Market by End User
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments
8.1.5.1 Acquisition and Mergers
8.1.5.2 Product Launches and Product Expansions
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments
8.2.5.1 Product Launches and Product Expansions
8.2.5.2 Partnerships, Collaborations, and Agreements
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments
8.3.5.1 Product Launches and Product Expansions
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments
8.4.4.1 Acquisition and Mergers
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments
8.5.5.1 Partnerships, Collaborations, and Agreements
8.5.5.2 Product Launches and Product Expansions
8.5.5.3 Geographical Expansions
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments
8.6.5.1 Partnerships, Collaborations, and Agreements
8.6.5.2 Product Launches and Product Expansions
8.6.5.3 Acquisition and Mergers
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments
8.7.5.1 Partnerships, Collaborations, and Agreements
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.8.5.2 Acquisition and Mergers
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10 Hero Nutritionals, Inc.
8.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...